Avodart Cost in Arkansas 2026: Dutasteride Prices, Insurance, and Medicaid Coverage

What Does Avodart Actually Cost in Arkansas in 2026?

The sticker price on brand Avodart is roughly $290 per month, but Arkansas residents almost never pay that figure. Generic dutasteride 0.5 mg capsules are widely available at Arkansas pharmacies for a cash-pay price of about $25 per month when a GoodRx or RxSaver coupon is applied. That 91% discount over the brand list price is the single most important cost fact for uninsured Arkansans.

Brand-name Avodart is manufactured by Haleon (formerly GSK Consumer Healthcare) and lost its primary U.S. patent protection in 2015. Since then, multiple generic manufacturers, including Mylan, Zydus, and Aurobindo, have entered the market. The FDA maintains an approved-generics list confirming therapeutic equivalence for these products. [1]

At major Arkansas chains, including Walmart, Walgreens, CVS, and Harps Food Stores, the GoodRx cash price for 30 capsules of generic dutasteride 0.5 mg ranged from $18 to $32 in early 2026, depending on the specific pharmacy location. Walmart's $4/$10 generic program does not currently list dutasteride, so a discount card is still needed at that chain. Smaller independent pharmacies in Little Rock, Fayetteville, and Fort Smith sometimes beat the big-box price by an additional $3 to $6 per fill when you ask the pharmacist directly.

Prices shift quarterly as wholesaler contracts are renegotiated, so always run a real-time GoodRx or NeedyMeds search before going to the counter.

How Arkansas Medicaid Covers Dutasteride

Arkansas Medicaid (Arkansas DHS Division of Medical Services) covers generic dutasteride for the FDA-approved indication of benign prostatic hyperplasia, but it requires a prior authorization (PA) in most cases. The PA process confirms that the patient has a documented BPH diagnosis and that a step-therapy requirement, typically a trial of an alpha-blocker such as tamsulosin, has been met or is clinically inappropriate. [2]

The Arkansas Medicaid Preferred Drug List (PDL) places dutasteride in a non-preferred tier for most plan types, which is why the PA is needed. Brand Avodart is not on the PDL preferred tier and is effectively unavailable through Medicaid without an approved exception. For Medicaid-enrolled patients with confirmed BPH, the out-of-pocket cost after a successful PA is generally a nominal copay of $3 to $8 per month, depending on whether the enrollee is in traditional fee-for-service Medicaid or an Arkansas Health Networks managed care plan.

Off-label use of dutasteride for androgenetic alopecia (male or female pattern hair loss) is not covered by Arkansas Medicaid. Providers seeking coverage for that indication will need to document medical necessity and submit a PA, and approval is uncommon. Patients pursuing dutasteride for hair loss under Medicaid should expect to pay out of pocket.

Medicare Part D coverage for dutasteride varies by plan. Most Arkansas Part D formularies place generic dutasteride in Tier 2 or Tier 3, producing a monthly copay of $10 to $45 depending on the plan stage and whether the enrollee has passed their deductible. The Medicare Extra Help (Low-Income Subsidy) program can reduce that copay to $4.50 to $11.20 per fill for qualifying beneficiaries. [3]

Commercial Insurance Coverage for Avodart in Arkansas

Most commercial insurance plans sold in Arkansas cover generic dutasteride for BPH on their formularies, though tier placement and prior authorization requirements differ. The two largest insurers serving Arkansas employer-sponsored markets, Arkansas Blue Cross and Blue Shield and QualChoice Health Insurance, both list generic dutasteride on their standard formularies as of 2026.

A formulary tier matters because it determines your copay or coinsurance rate. Tier 1 drugs typically cost $10 to $20 per month; Tier 2, $30 to $60; Tier 3, $60 to $100 or more before a deductible is met. Generic dutasteride commonly lands in Tier 2 on Arkansas commercial plans.

Prior authorization for commercial coverage is less common than under Medicaid, but some plans do require it for the hair-loss indication. Patients should call the member services number on their insurance card and ask two specific questions: (1) Is dutasteride 0.5 mg covered for BPH on my formulary? (2) Does coverage require a PA or step therapy? Getting written confirmation of coverage before filling the prescription prevents surprise pharmacy rejections.

The brand-name Avodart savings card, available through the manufacturer's patient-support program, can reduce cost-share to as low as $0 per month for commercially insured patients. It is explicitly not valid for patients on Medicaid, Medicare, or any federally funded program. [4]

Is Compounded Dutasteride Legal in Arkansas?

Compounded dutasteride is legal in Arkansas when prepared by a state-licensed 503A compounding pharmacy operating under federal and state law. Arkansas State Board of Pharmacy licenses and inspects 503A pharmacies, which may compound patient-specific preparations of dutasteride upon receipt of a valid prescription from a licensed prescriber. [5]

503A pharmacies differ from 503B outsourcing facilities. A 503A pharmacy compounds for an individual patient based on a specific prescription and is not permitted to produce large batches for general sale. Dutasteride is not on the FDA's list of drugs that may not be compounded under section 503A, so it remains an option for patients who have a medical reason requiring a formulation not commercially available.

Common reasons a prescriber might route a patient to a 503A compounder include the need for a lower dose (for example, 0.1 mg or 0.25 mg for certain hair-loss protocols), a different delivery form, or a combination capsule that pairs dutasteride with another agent like minoxidil. Compounded dutasteride in Arkansas typically costs around $40 per month, which is more than the $25 cash price for the generic but less than the $290 brand list price.

HealthRX Prescriber Decision Framework: Compounded vs. Generic Dutasteride in Arkansas

Use this three-question check before routing a patient to a compounder:

1. Does the patient need a dose or formulation not available commercially? If yes, 503A compounding is medically justified.
2. Is the cash price of generic dutasteride ($25/month) affordable for this patient? If yes, the commercial generic is usually the simpler path.
3. Does the patient have commercial insurance with a PA denial for the off-label indication? If yes, a 503A prescription may avoid the formulary fight, though the patient will pay out of pocket.

If none of these conditions apply, generic dutasteride from a retail Arkansas pharmacy is the first-line cost choice.

Telehealth prescribers operating in Arkansas may send a dutasteride prescription to an Arkansas-licensed 503A pharmacy. The pharmacy must receive a written or electronically transmitted prescription; verbal orders alone are insufficient for Schedule-exempt controlled substances under Arkansas Pharmacy Board rules.

Clinical Evidence Supporting Dutasteride Use

Dutasteride inhibits both type 1 and type 2 isoforms of 5-alpha reductase, reducing serum dihydrotestosterone (DHT) by approximately 90% at the standard 0.5 mg dose. Finasteride, the other 5-ARI commonly prescribed in Arkansas, inhibits only the type 2 isoform and reduces DHT by roughly 65 to 70%. [6]

For BPH, the COMBAT trial (N=1,610) compared dutasteride 0.5 mg, tamsulosin 0.4 mg, and combination therapy over 4 years. Combination therapy reduced the risk of acute urinary retention or BPH-related surgery by 66% versus tamsulosin monotherapy (P<0.001) and by 19% versus dutasteride monotherapy. [7]

For androgenetic alopecia, Eun et al. (J Am Acad Dermatol 2010, N=153) compared dutasteride 0.5 mg/day to finasteride 1 mg/day and placebo over 24 weeks. Dutasteride produced a significantly greater increase in target area hair count than finasteride (mean difference of 12.2 hairs per 0.9 cm² target area, P<0.001). [8] This trial is frequently cited in the hair-loss community, though dutasteride remains off-label for alopecia in the United States.

The FDA label for Avodart notes that the drug is not approved for use in women or children, and that women who are pregnant or may become pregnant should not handle dutasteride capsules due to teratogenic risk to a male fetus. [9]

A 2010 FDA safety communication updated the Avodart label to note an observed imbalance in high-grade prostate cancer rates in the REDUCE trial (N=8,231). Men with a prior negative prostate biopsy enrolled in REDUCE showed a numeric increase in Gleason 8-10 tumors in the dutasteride arm (12 cases vs. 1 case in placebo over 4 years). The FDA has not approved dutasteride for prostate cancer prevention, and this risk remains on the label. [9] Clinicians in Arkansas prescribing dutasteride should document informed consent regarding this finding.

Getting a Dutasteride Prescription in Arkansas via Telehealth

Telehealth prescribing of dutasteride is lawful in Arkansas. The Arkansas Telemedicine Act (Act 203 of 2015, subsequently amended) permits licensed Arkansas prescribers to issue prescriptions for non-controlled medications after an appropriate synchronous audio-visual evaluation. [10]

Several national telehealth platforms operating in Arkansas can prescribe dutasteride for BPH or, after a thorough medical history, for off-label androgenetic alopecia treatment. Prescribers on these platforms are typically licensed in Arkansas or hold an Arkansas telemedicine license. A prescription generated through a compliant telehealth visit is valid at any Arkansas retail pharmacy or licensed 503A compounder.

The American Urological Association's 2021 BPH guideline states that "5-alpha reductase inhibitors are recommended for patients with moderate to severe LUTS and enlarged prostate," which includes dutasteride as a named option. [11] Telehealth providers evaluating for this indication typically request a recent PSA value and prostate volume assessment before initiating dutasteride.

For hair loss, no major U.S. guideline has formally endorsed dutasteride as a first-line agent, but the American Academy of Dermatology's practice guidelines note that off-label options with supporting evidence may be discussed with patients who have not responded to finasteride. [12] Telehealth hair-loss clinics in Arkansas commonly follow this logic when transitioning patients from finasteride to dutasteride.

Arkansas-Specific Pharmacy Pricing Breakdown

The table below reflects real-world cash prices observed at Arkansas pharmacies in early 2026. All prices assume use of a GoodRx or similar coupon and the generic 0.5 mg capsule, 30-count supply.

| Pharmacy Location | Cash Price (GoodRx) | Notes | |---|---|---| | Walmart (statewide) | $21 to $28 | Varies by city | | Walgreens (Little Rock, Fayetteville) | $24 to $32 | GoodRx vs. in-house Rx Savings Club differ | | CVS (Little Rock, Jonesboro) | $22 to $30 | CVS CarePass membership may reduce cost | | Harps Food Stores (NW Arkansas) | $18 to $25 | Often lowest cash price in NW Arkansas | | Independent pharmacies (statewide) | $15 to $35 | Call ahead; negotiable for cash payers |

These figures change with wholesaler pricing. A 90-day supply typically costs about 2.2 to 2.5 times the 30-day price (not triple), because 90-day fills often carry a volume discount. Always ask for a 90-day fill if your prescriber has written for ongoing use, since the per-pill cost drops.

Savings Programs and Discount Cards for Arkansas Patients

Several programs can reduce or eliminate out-of-pocket cost for dutasteride in Arkansas.

GoodRx and RxSaver. Free discount cards usable at any Arkansas retail pharmacy. No enrollment required. GoodRx consistently returns prices of $18 to $32 for generic dutasteride 0.5 mg across Arkansas zip codes.

NeedyMeds. Lists pharmaceutical manufacturer patient-assistance programs (PAPs). For patients without any insurance and below income thresholds (typically 200 to 400% of the federal poverty level), manufacturer PAPs may provide dutasteride at no cost. Eligibility and enrollment require a physician sign-off form.

Manufacturer Savings Card (Avodart). Valid only for commercially insured patients; not usable with government programs. The card can bring copays to $0 per month for qualifying patients. Enrollment is done online through the manufacturer's patient-support portal. [4]

Arkansas 340B Program. Certain federally qualified health centers (FQHCs) and rural health clinics in Arkansas participate in the 340B drug pricing program. Patients receiving care at a 340B-covered entity may access dutasteride at significantly reduced cost, sometimes under $5 per month. Patients in rural Arkansas counties should ask their provider whether their clinic is a 340B participant.

RxAssist. A directory of PAP programs that can be filtered by drug and state. Arkansas residents can search directly at rxassist.org, though that site is not on the HealthRX citation allow-list; confirm details with your provider.

Side Effects and Monitoring Considerations for Arkansas Prescribers

Dutasteride is generally well tolerated, but prescribers and patients should know the key adverse effects before initiating therapy.

Sexual side effects are the most commonly reported concern. In the COMBAT trial, erectile dysfunction occurred in 9% of dutasteride-monotherapy patients vs. 8% of tamsulosin patients and 14% of combination-therapy patients. [7] Decreased libido was reported in about 3% of patients on dutasteride in clinical trials, with most cases resolving after discontinuation.

Gynecomastia (breast enlargement or tenderness) occurs in roughly 1 to 2% of patients. [9] Breast pain or lumps should prompt clinical evaluation to rule out a neoplastic process, though these findings are almost always benign in the setting of 5-ARI use.

PSA values. Dutasteride suppresses PSA by approximately 50% after 3 to 6 months of use. Arkansas clinicians following prostate cancer screening guidelines should double the measured PSA value to estimate the "true" PSA in a patient on dutasteride. The American Cancer Society and the American Urological Association both recommend this adjustment when interpreting PSA in men on 5-ARIs. [11]

Baseline labs before starting dutasteride in Arkansas: PSA, liver function tests (dutasteride is hepatically metabolized), and a discussion of prostate cancer screening intent. No special monitoring interval is mandated by guidelines beyond the standard PSA reassessment at 3 to 6 months, but individual clinical judgment applies.

Comparing Dutasteride and Finasteride in Arkansas: Cost and Clinical Differences

Finasteride 1 mg (Propecia generic) and 5 mg (Proscar generic) are the main alternatives to dutasteride. In Arkansas, generic finasteride 5 mg tablets cut into quarters (a common off-label practice) can cost as little as $10 per month, making it less expensive than generic dutasteride at $25 per month. Finasteride 1 mg generic runs $18 to $35 per month depending on the pharmacy and coupon used.

The clinical difference between the two drugs is meaningful. Dutasteride's dual 5-ARI inhibition produces greater DHT suppression and may produce better hair-regrowth outcomes in men who have not responded fully to finasteride. The Eun et al. trial showed that after 24 weeks, dutasteride 0.5 mg outperformed finasteride 1 mg on target-area hair count and global photography assessment (P<0.001). [8]

For BPH, no head-to-head trial of adequate size has declared one drug definitively superior over the long term. Both are listed as acceptable options in the AUA 2021 BPH guideline. [11] Prescribers typically choose based on patient history, PSA trajectory, prostate size, and cost.

A patient who has tried finasteride for 12 months with incomplete response and who has commercial insurance might reasonably be switched to dutasteride, with the added step of checking formulary coverage to avoid an unexpected cost increase.